4
Changes in Ownership
NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001709738-26-000007
Business Development Director sold 13,720 shares at $0.80 ($10,976)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Christianson Mark Business Development Director | 2026-03-10 | Sale | −11,611 | $0.80 | $9,289 | 217,309 | D: show line 1 in the form |
| Christianson Mark Business Development Director | 2026-03-11 | Sale | −2,109 | $0.80 | $1,687 | 215,200 | D: show line 2 in the form |
| Open-market sales · 13,720 sh · avg $0.80 · $10,976 | |||||||
Loading xslF345X05/primary_doc.xml…